Literature DB >> 22100520

Decreased nucleotide excision repair in steatotic livers associates with myeloperoxidase-immunoreactivity.

Marten A Schults1, Peter W Nagle, Sander S Rensen, Roger W Godschalk, Armelle Munnia, Marco Peluso, Sandra M Claessen, Jan W Greve, Ann Driessen, Froukje J Verdam, Wim A Buurman, Frederik J van Schooten, Roland K Chiu.   

Abstract

Chronic inflammation is characterized by the influx of neutrophils and is associated with an increased production of reactive oxygen species that can damage DNA. Oxidative DNA damage is generally thought to be involved in the increased risk of cancer in inflamed tissues. We previously demonstrated that activated neutrophil mediated oxidative stress results in a reduction in nucleotide excision repair (NER) capacity, which could further enhance mutagenesis. Inflammation and oxidative stress are critical factors in the progression of nonalcoholic fatty liver disease that is linked with enhanced liver cancer risk. In this report, we therefore evaluated the role of neutrophils and the associated oxidative stress in damage recognition and DNA repair in steatotic livers of 35 severely obese subjects with either nonalcoholic steatohepatitis (NASH) (n=17) or steatosis alone (n=18). The neutrophilic influx in liver was assessed by myeloperoxidase (MPO) staining and the amount of oxidative DNA damage by measuring M(1)dG adducts. No differences in M(1)dG adduct levels were observed between patients with or without NASH and also not between individuals with high or low MPO immunoreactivity. However, we found that high expression of MPO in the liver, irrespective of disease status, reduced the damage recognition capacity as determined by staining for histone 2AX phosphorylation (γH2AX). This reduction in γH2AX formation in individuals with high MPO immunoreactivity was paralleled by a significant decrease in NER capacity as assessed by a functional repair assay, and was not related to cell proliferation. Thus, the observed reduction in NER capacity upon hepatic inflammation is associated with and may be a consequence of reduced damage recognition. These findings suggest a novel mechanism of liver cancer development in patients with nonalcoholic fatty liver disease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100520     DOI: 10.1016/j.mrfmmm.2011.11.001

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  13 in total

Review 1.  The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease.

Authors:  Marina Nati; Kyoung-Jin Chung; Triantafyllos Chavakis
Journal:  J Innate Immun       Date:  2021-08-24       Impact factor: 7.349

2.  Detection of carcinogenic etheno-DNA adducts in children and adolescents with non-alcoholic steatohepatitis (NASH).

Authors:  Ulrike Teufel; Teresa Peccerella; Guido Engelmann; Thomas Bruckner; Christa Flechtenmacher; Gunda Millonig; Felix Stickel; Georg F Hoffmann; Peter Schirmacher; Sebastian Mueller; Helmut Bartsch; Helmut K Seitz
Journal:  Hepatobiliary Surg Nutr       Date:  2015-12       Impact factor: 7.293

3.  Prognostic Value of the Expression of DNA Repair-Related Biomarkers Mediated by Alcohol in Gastric Cancer Patients.

Authors:  Yiyin Zhang; Hongyang Wu; Feng Yang; Jie Ning; Min Li; Chenchen Zhao; Shuping Zhong; Kangsheng Gu; Hua Wang
Journal:  Am J Pathol       Date:  2018-01-10       Impact factor: 4.307

Review 4.  The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH).

Authors:  Marina Nati; David Haddad; Andreas L Birkenfeld; Christian A Koch; Triantafyllos Chavakis; Antonios Chatzigeorgiou
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

Review 5.  From NASH to HCC: current concepts and future challenges.

Authors:  Quentin M Anstee; Helen L Reeves; Elena Kotsiliti; Olivier Govaere; Mathias Heikenwalder
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-07       Impact factor: 46.802

Review 6.  Potential epigenetic mechanism in non-alcoholic Fatty liver disease.

Authors:  Chao Sun; Jian-Gao Fan; Liang Qiao
Journal:  Int J Mol Sci       Date:  2015-03-05       Impact factor: 5.923

7.  Simvastatin Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in Nonalcoholic Steatohepatitis Experimental Model.

Authors:  Graziella Rodrigues; Andrea Janz Moreira; Silvia Bona; Elizângela Schemitt; Cláudio Augusto Marroni; Fábio Cangeri Di Naso; Alexandre Simões Dias; Thienne Rocha Pires; Jaqueline Nascimento Picada; Norma Possa Marroni
Journal:  Oxid Med Cell Longev       Date:  2019-06-18       Impact factor: 6.543

Review 8.  Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC.

Authors:  Yueqi Zhang; Hongbing Wang; Hua Xiao
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

9.  Impact of liver PGC-1α on exercise and exercise training-induced regulation of hepatic autophagy and mitophagy in mice on HFF.

Authors:  Maja M Dethlefsen; Caroline M Kristensen; Anna S Tøndering; Signe B Lassen; Stine Ringholm; Henriette Pilegaard
Journal:  Physiol Rep       Date:  2018-07

10.  Exocycilic DNA Adducts in a Murine Model of Non-alcoholic Steatohepatitis.

Authors:  Marco E M Peluso; Armelle Munnia; Mirko Tarocchi; Mario Arciello; Clara Balsano; Roger W Giese; Andrea Galli
Journal:  J Carcinog Mutagen       Date:  2013-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.